Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P. falciparum Dihydroorotate Dehydrogenase. 2017

Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.

Dihydroorotate dehydrogenase (DHODH) is an enzyme necessary for pyrimidine biosynthesis in protozoan parasites of the genus Plasmodium, the causative agents of malaria. We recently reported the identification of novel compounds derived from diversity-oriented synthesis with activity in multiple stages of the malaria parasite life cycle. Here, we report the optimization of a potent series of antimalarial inhibitors consisting of azetidine-2-carbonitriles, which we had previously shown to target P. falciparum DHODH in a biochemical assay. Optimized compound BRD9185 (27) has in vitro activity against multidrug-resistant blood-stage parasites (EC50 = 0.016 μM) and is curative after just three doses in a P. berghei mouse model. BRD9185 has a long half-life (15 h) and low clearance in mice and represents a new structural class of DHODH inhibitors with potential as antimalarial drugs.

UI MeSH Term Description Entries

Related Publications

Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
March 1992, Biochemical pharmacology,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
July 2023, Future medicinal chemistry,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
August 2018, ACS omega,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
January 2016, SAR and QSAR in environmental research,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
June 2016, Journal of medicinal chemistry,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
January 2023, Expert opinion on therapeutic patents,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
November 2021, ACS chemical biology,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
September 2011, ACS medicinal chemistry letters,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
August 1993, Molecular and biochemical parasitology,
Micah Maetani, and Nobutaka Kato, and Valquiria A P Jabor, and Felipe A Calil, and Maria Cristina Nonato, and Christina A Scherer, and Stuart L Schreiber
January 2017, European journal of medicinal chemistry,
Copied contents to your clipboard!